Scientists Propose Creating Unique Identification Codes for Biobanks

All biobanks (collections of human biological samples) should be given a unique identification code, EU-funded scientists suggest. Writing in the Journal of the American Medical Association (JAMA), they argue that such a scheme would optimise the use of these resources and open up new avenues for genetics studies.

Biobanks consist of samples of human biological material such as blood or tissue, together with the data associated with them such as clinical information. They are often used in wide-ranging studies designed to identify the genes associated with a particular disease or condition, for example. Ultimately the results of these studies can lead to the development of new treatments.

However, these studies require large numbers of samples to carry out reliable statistical analyses. Obtaining this critical mass of samples would be easier if researchers could find and access data from other biobanks. The problem is that it is currently very difficult to trace biobanks.

To overcome this problem, the authors propose that each biobank be allocated a unique, structured code, similar to the International Standard Book Number (ISBN), which has been used in the book world for over 40 years. The ISBN is made up of a number of elements identifying the language or geographical region, the publisher and the specific edition of the publication.

A similar system could be applied to biobanks, with the different elements identifying the custodian of the biobank, its home country, and the individual collection. If set up along the same lines as the ISBN system, "it would be easy to identify a biological collection, the various surveys in a longitudinal study, or an international programme made of collections built up in various countries," the authors claim.

Biobanks would receive their code at the time of ethical approval, and the system could be applied retroactively to existing studies and collections.

The authors are clear about the advantages offered by their system. Firstly, it would permit individuals to trace the uses made of a given biobank and find out the results generated.

By including information on the collector of the samples and data, such a system could also provide recognition of the hard work involved in building up a biobank.

The registration number could also be given to study participants, enabling them to follow the use of the collection and see how their sample and data are being used, even if they are anonymised.

Some questions still remain to be answered, such as who would maintain the system, who would fund it, and how uptake would be ensured.

The EU projects supporting the proposal are: GA2LEN ('Global allergy and asthma European network') and PHOEBE ('Promoting the harmonisation of epidemiological biobanks in Europe'), both of which are financed under the Sixth Framework Programme, and GEN2PHEN ('Genotype to phenotype databases: a holistic solution') and BBMRI ('Biobanking and biomolecular resources research infrastructure'), both of which are funded through the Seventh Framework Programme (FP7).

For further information, please visit:
http://www.jama.com

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...